UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
FBR Capital Cuts Price Target on Athenahealth (ATHN) Following 2Q Miss
July 22, 2016 7:13 AM EDTFBR Capital reiterated a Market Perform rating on Athenahealth (NASDAQ: ATHN), and cut the price target to $140.00 (from $145.00), following the company's 2Q earnings report. Revenue was $262 million, below the consensus of $274 million. Non-GAAP adjusted EPS was $0.34, compared with the consensus of $0.42.
Analyst Steven Halper... More
Deutsche Bank Downgrades athenahealth (ATHN) to Hold
July 22, 2016 6:58 AM EDTDeutsche Bank downgraded athenahealth (NASDAQ: ATHN) from Buy to Hold with a price target of $147.00 (from $165.00). Analyst George Hill pointed out disturbing underlying performance metrics.
"Athena reported concerning Q2 results after market close, where the revenue and earnings miss was among the... More
